Free Trial

Nuvectis Pharma (NVCT) Institutional Ownership

Nuvectis Pharma logo
$7.78 +0.05 (+0.65%)
Closing price 04:00 PM Eastern
Extended Trading
$7.98 +0.20 (+2.57%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)

Current
Institutional Ownership
Percentage
96.77%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$7.41M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$438.30K
Get NVCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NVCT Institutional Buying and Selling by Quarter

Nuvectis Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/24/2025 Baldwin Wealth Partners LLC MA350,461$2.62M0.2%-2.2%1.678%
6/27/2025Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218%
5/19/2025Jane Street Group LLC42,299$413K0.0%N/A0.202%
5/16/2025Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218%
5/15/2025OMERS ADMINISTRATION Corp32,882$321K0.0%N/A0.139%
5/1/2025Austin Wealth Management LLC40,250$393K0.1%N/A0.172%
4/30/2025Iridian Asset Management LLC CT253,972$2.48M0.8%N/A1.086%
4/23/2025Oppenheimer & Co. Inc.41,000$401K0.0%+64.0%0.175%
4/14/2025 Baldwin Wealth Partners LLC MA358,461$3.50M0.2%+0.7%1.532%
4/11/2025 Blue Zone Wealth Advisors LLC10,424$102K0.0%N/A0.045%
2/17/2025Squarepoint Ops LLC19,071$103K0.0%N/A0.099%
2/17/2025Two Sigma Investments LP18,570$100K0.0%-30.7%0.096%
2/17/2025Millennium Management LLC29,698$161K0.0%-56.6%0.154%
2/17/2025Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033%
2/14/2025Northern Trust Corp25,725$139K0.0%+68.7%0.133%
2/13/2025Marshall Wace LLP124,571$674K0.0%+191.0%0.645%
2/12/2025Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079%
2/12/2025 Baxter Bros Inc.15,000$81K0.0%+20.0%0.078%
2/5/2025Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129%
1/30/2025Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070%
1/28/2025 Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305%
1/22/2025 Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842%
11/16/2024Geode Capital Management LLC79,716$501K0.0%+49.8%0.413%
11/5/2024 GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269%
11/5/2024Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054%
10/25/2024Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297%
9/16/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050%
8/15/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050%
8/14/2024Marshall Wace LLP33,868$214K0.0%-32.4%0.185%
8/9/2024Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406%
7/16/2024 Baxter Bros Inc.12,500$79K0.0%N/A0.068%
7/12/2024 Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918%
5/10/2024Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626%
4/18/2024 Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081%
2/12/2024Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111%
1/30/2024Strs Ohio6,200$51K0.0%+59.0%0.036%
1/8/2024 Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820%
11/2/2023 Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197%
10/26/2023Strs Ohio3,900$50K0.0%+178.6%0.023%
10/10/2023 Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675%
The Private Market Surge Is Coming in 2025 (Ad)

The most lucrative investment opportunities are reserved for a select category of investor. They're private. They're quiet. And they're often available exclusively to accredited investors operating outside the noise of the public markets. We're talking about off-market placements, early venture deals, private credit, and pre-IPO shares—the kind of plays that can generate outsized gains before Wall Street catches wind. Here's the reality: having access is only the beginning. These deals can be opaque, rushed, and filled with hidden risk. That's why we created something exclusively for investors like you—the 2025 Accredited Investor Playbook.

Get your copy now: [Access the 2025 Accredited Investor Playbook]
8/10/2023Hollencrest Capital Management3,040$49K0.0%N/A0.019%
8/4/2023American International Group Inc.3,298$53K0.0%N/A0.021%
8/3/2023 Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418%
8/2/2023Bank of Montreal Can11,012$200K0.0%N/A0.069%
7/14/2023 Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563%
5/11/2023Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167%
4/21/2023 Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975%
11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843%
10/14/2022 Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908%
8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297%
7/18/2022 Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951%
5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325%
(Data available from 1/1/2016 forward)

NVCT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NVCT shares?

During the previous two years, 28 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Baldwin Wealth Partners LLC MA ($2.62M), Iridian Asset Management LLC CT ($2.48M), Vanguard Group Inc. ($2.45M), Baldwin Brothers LLC MA ($1.07M), Marshall Wace LLP ($674K), Geode Capital Management LLC ($501K), and Renaissance Technologies LLC ($472K).Learn more on Nuvectis Pharma's institutional investors.

What percentage of Nuvectis Pharma's stock is owned by institutional investors?

96.77% of Nuvectis Pharma's stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings.

Which institutional investors have been buying Nuvectis Pharma's stock?

Of the 26 institutional investors that purchased Nuvectis Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Iridian Asset Management LLC CT ($309.35K), Baldwin Wealth Partners LLC MA ($184.33K), Goldman Sachs Group Inc. ($91.22K), Marshall Wace LLP ($81.76K), Forbes J M & Co. LLP ($77.60K), Baldwin Brothers LLC MA ($66.48K), and Jane Street Group LLC ($42.30K).

How much institutional buying is happening at Nuvectis Pharma?

Institutional investors have bought a total of 955,432 shares in the last 24 months. This purchase volume represents approximately $7.41M in transactions.

Which of Nuvectis Pharma's major shareholders have been selling company stock?

The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Millennium Management LLC ($38.80K), Marshall Wace LLP ($16.20K), Two Sigma Investments LP ($8.22K), Baldwin Wealth Partners LLC MA ($8K), and Edmond DE Rothschild Holding S.A. ($4K).

How much institutional selling is happening at Nuvectis Pharma?

Institutional investors have sold a total of 75,216 shares in the last 24 months. This volume of shares sold represents approximately $438.30K in transactions.



This page (NASDAQ:NVCT) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners